Search: onr:"swepub:oai:gup.ub.gu.se/222972" >
Automated astatinat...
-
Aneheim, Emma,1982Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för radiofysik,Institute of Clinical Sciences, Department of Radiation Physics,University of Gothenburg
(author)
Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.
- Article/chapterEnglish2015
Publisher, publication year, extent ...
-
2015-07-14
-
Springer Science and Business Media LLC,2015
Numbers
-
LIBRIS-ID:oai:gup.ub.gu.se/222972
-
https://gup.ub.gu.se/publication/222972URI
-
https://doi.org/10.1038/srep12025DOI
-
https://research.chalmers.se/publication/222972URI
Supplementary language notes
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
To facilitate multicentre clinical studies on targeted alpha therapy, it is necessary to develop an automated, on-site procedure for conjugating rare, short-lived, alpha-emitting radionuclides to biomolecules. Astatine-211 is one of the few alpha-emitting nuclides with appropriate chemical and physical properties for use in targeted therapies for cancer. Due to the very short range of the emitted α-particles, this therapy is particularly suited to treating occult, disseminated cancers. Astatine is not intrinsically tumour-specific; therefore, it requires an appropriate tumour-specific targeting vector, which can guide the radiation to the cancer cells. Consequently, an appropriate method is required for coupling the nuclide to the vector. To increase the availability of astatine-211 radiopharmaceuticals for targeted alpha therapy, their production should be automated. Here, we present a method that combines dry distillation of astatine-211 and a synthesis module for producing radiopharmaceuticals into a process platform. This platform will standardize production of astatinated radiopharmaceuticals, and hence, it will facilitate large clinical studies focused on this promising, but chemically challenging, alpha-emitting radionuclide. In this work, we describe the process platform, and we demonstrate the production of both astaine-211, for preclinical use, and astatine-211 labelled antibodies.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Albertsson, Per,1964Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för radiofysik,Institute of Clinical Sciences, Department of Radiation Physics,University of Gothenburg(Swepub:gu)xalbpe
(author)
-
Bäck, Tom,1964Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för radiofysik,Institute of Clinical Sciences, Department of Radiation Physics,University of Gothenburg(Swepub:gu)xbackt
(author)
-
Jensen, Holger
(author)
-
Palm, Stig,1964Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för radiofysik,Institute of Clinical Sciences, Department of Radiation Physics,University of Gothenburg(Swepub:gu)xpalst
(author)
-
Lindegren, Sture,1960Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för radiofysik,Institute of Clinical Sciences, Department of Radiation Physics,University of Gothenburg(Swepub:gu)xlistu
(author)
-
Göteborgs universitetInstitutionen för kliniska vetenskaper, Avdelningen för radiofysik
(creator_code:org_t)
Related titles
-
In:Scientific reports: Springer Science and Business Media LLC52045-2322
Internet link
Find in a library
To the university's database
- By the author/editor
-
Aneheim, Emma, 1 ...
-
Albertsson, Per, ...
-
Bäck, Tom, 1964
-
Jensen, Holger
-
Palm, Stig, 1964
-
Lindegren, Sture ...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Radiology Nuclea ...
- Articles in the publication
-
Scientific repor ...
- By the university
-
University of Gothenburg
-
Chalmers University of Technology